Name (Synonyms) | Correlation | |
---|---|---|
drug621 | L-ascorbic acid Wiki | 0.71 |
drug850 | Placebo Wiki | 0.09 |
Name (Synonyms) | Correlation | |
---|---|---|
D014947 | Wounds and Injuries NIH | 0.32 |
D055370 | Lung Injury NIH | 0.25 |
D055371 | Acute Lung Injury NIH | 0.13 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.11 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Objective: To assess whether adjunctive therapy of COVID-19 infection with atorvastatin reduces the deterioration in hospitalized patients and improves clinical outcome.
Description: Proportion of patients in each arm that progress to severe or critical requiring ICU admission and/or emergency salvage therapy, or death, as described by WHO Ordinal Scale for Clinical Improvement scores 5-8 with higher being worse.
Measure: Proportion of patients that progress to severe or critical requiring ICU admission and/or emergency salvage therapy, or death Time: 30 daysDescription: Description of clinical status of patients in each arm based on WHO Ordinal Scale of Clinical Improvement on Day 7, scores 1-8 with higher being worse.
Measure: Overall score of patients in each arm on Day 7 based on WHO Ordinal Scale for Clinical Improvement Time: 7 daysDescription: Description of clinical status of patients in each arm based on WHO Ordinal Scale of Clinical Improvement on Day 30, scores 1-8 with higher being worse.
Measure: Overall score of patients in each arm on Day 30 based on WHO Ordinal Scale for Clinical Improvement Time: 30 daysDescription: Proportions of patients in each arm who are tested on Day 7 and have negative PCR
Measure: Proportions of patients in each arm who test negative for SARS-CoV-2 on Day 7 Time: 7 days